Results 221 to 230 of about 1,069,369 (339)

Deciding to Be Left Alone After Being Left Out: Behavioral Responses to Social Exclusion in Schizophrenia. [PDF]

Schizophr Bull
Weittenhiller LP, Kring AM.
europepmc   +1 more source

Alogliptin Reduces Oxidative Stress in Cardiomyocytes and Ameliorates Diabetic Cardiomyopathy via the AURKB/NLGN2 Signaling

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao, Jing Zhou, Jing Wang, Si‐Nan Zhao, Zhan‐Sheng Zhao, Qian Wang, Ya‐Nan Xie, Wei Jiao   +7 more
wiley   +1 more source

Five differentially expressed proteins identified to serve as potential blood biomarkers for schizophrenia screening based on proteomics. [PDF]

Front Psychiatry
Li R, Fu X, Li C, Yuan L, Liu Y, Yang L, Fang X, Zhang X, Zhang G, Du X.   +9 more
europepmc   +1 more source

Gender‐Affirming Feminization Voice Surgery: A Scoping Review of Preoperative Assessments

The Laryngoscope, EarlyView.
PRISMA flowchart. ABSTRACT Objective To identify the preoperative assessments and criteria surgeons use to assess the suitability of transfeminine patients for voice feminization surgery. Data Sources Electronic search of Ovid MEDLINE, Ovid Embase, APA PsycINFO, Cochrane Library, CINAHL, and PubMed excluding MEDLINE records was performed on February 11,
Jadin Chahade, Hedieh Keshavars, Janice Y. Kung, Teresa L. D. Hardy, Caroline C. Jeffery   +4 more
wiley   +1 more source

Mapping the Scientific Landscape of Schizophrenia Genetics (2020-2025): A Bibliometric and Scientometric Study of Global Trends and Collaborations. [PDF]

Brain Behav
Mikaeili N, Naeim M, Narimani M.
europepmc   +1 more source

Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma, Panagiota Tsitsi, Nirosen Vijiaratnam, Camila Aquino, Stephen R. Duma, Norbert Kovacs, Kigocha Lameck Okeng'o, Aparna Wagle Shukla, Roongroj Bhidayasiri, Tiago A. Mestre, Alvaro Sanchez Ferro, Alberto J. Espay, Michelle H.S. Tosin, Matej Skorvanek, Ioanna Markaki   +14 more
wiley   +1 more source

Altered cortical-striatal circuits connectivity is associated with psychotic symptoms in patients with first-episode, drug-naïve early-onset schizophrenia. [PDF]

Front Psychiatry
Wang L, Liu R, Liao J, Li F, Zhuo L, Li H.   +5 more
europepmc   +1 more source

Basal Forebrain Volume and Concurrent Hallucinations and Mild Cognitive Impairment in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Visual hallucinations (VH) and mild cognitive impairment (MCI) often co‐occur in Parkinson's Disease (PD). Each symptom in isolation is associated with cholinergic basal forebrain (BF) atrophy. However, it is unclear whether BF integrity relates to one symptom preferentially or to their co‐occurrence, and whether this relationship ...
Sabrina M. Adamo, Vaishali Mutreja, Marta Statucka, Batu Kaya, Taylor W. Schmitz, Anthony C. Ruocco, Melanie Cohn   +6 more
wiley   +1 more source

Circulating Orexin-A Levels in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Almahwzi S, Ghabashi S, Alyami W, Alsolami J, Juma R, Alghamdi S, Althobyane L, Alqahtani M, Alotaibi M.   +8 more
europepmc   +1 more source

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source